临床质谱分析市场按产品类型、应用、最终用户和地区划分

临床质谱市场预计在 2026 年达到 44.4 亿美元，预计到 2033 年将达到 67.6 亿美元，2026 年至 2033 年的复合年增长率为 6.14%。

临床质谱技术在药物研发和个人化医疗中发挥着至关重要的作用。它也被用于生物组织样本的生物成像，以检测生物标记。降低成本和提高检测品质是推动质谱技术普及应用的主要因素。据美国临床化学协会 (AACC) 称，液相层析法质谱联用 (LC-MS) 的高特异性使其能够检测内源性睪固酮水平低的患者体内的睪固酮水平。该技术比传统的免疫检测更可靠，尤其适用于女性和儿童。这促使研究实验室儘早采用基于成熟技术的最新一代仪器。

临床诊断质谱仪能够同时分析有限范围的样本，例如生物标记、蛋白质和药物分子，并且能够分析低浓度样本。

这包括低浓度。因此，这些仪器是诊断和实验室环境中的宝贵工具。此外，它们还使研究人员能够确定微量给药的药物的药物动力学特征。由于高解析度技术（例如四极飞行时间以及对这类光谱技术的需求预计将迅速增长。

市场动态

预计主要企业的技术创新和产品推出将推动临床质谱市场的成长。技术进步包括质谱仪的小型化和分析单元自动化程度的提高，从而减少人工操作并提高仪器效率。例如，赛默飞世尔科技于2017年6月发布了一款全自动分析仪，可客製化以相容于实验室资讯系统。

本次调查的主要特点

• 本报告以 2025 年为基准年，对预测期（2026-2033 年）内全球临床质谱市场规模进行了详细分析。
• 我们重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业的竞争策略的重要见解。
• 该报告根据以下参数对全球临床质谱市场的主要参与者进行了分析：公司概况、财务表现、产品系列、地理分布、主要发展和策略。
• 本报告的研究结果将使企业负责人和经营团队能够就未来的产品发布、政府倡议、市场扩张和行销策略做出明智的决策。
• 这份全球临床质谱分析报告的目标受众是该行业的各种相关人员，包括投资者、产品製造商、经销商、临床质谱仪供应商、研究和咨询公司、新参与企业和金融分析师。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场概览

• 报告概述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、监理及趋势分析

• 市场动态
  • 司机
  • 抑制因素
  • 市场机会
• 影响分析
• 市场趋势
• 重大进展
• 监管状态
• 波特五力模型

4. 2026-2033年全球临床品质分析市场（依产品类型划分）

• 气相层析层析法联用（GC-MS）
• 液相层析法质谱（LC-MS）
• MALDI-TOF质谱仪
• 毛细管电泳质谱法
• 离子移动率谱-质谱

5. 2026-2033年全球临床品质分析市场（依应用领域划分）

• 实验室测试
• 蛋白质体学
• 药物发现

6. 2026-2033年全球临床质谱分析市场（依最终使用者划分）

• 医院
• 研究所
• 诊断实验室

7. 2026-2033年全球临床品质分析市场（按地区划分）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 日本
  • 印度
  • ASEAN
  • 澳洲
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲国家
• 非洲
  • 北非
  • 中非
  • 南非
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家

第八章 竞争情势

• 公司简介
  • Bruker Corporations
  • Kore Technologies
  • Bergman Messgerate Entwicklung KG
  • Mass Spectrometry Instruments（MSI）
  • RGB Photonics
  • ABLE Biosciences
  • Thermo Fisher Scientific Inc.
  • Danaher Corporations
  • Agilent Technologies
  • Shimadzu Corporation
  • PerkinElmer Inc.

第九章各节

• 参考
• 调查方法

Clinical Mass Spectrometry Market is estimated to be valued at USD 4.44 Bn in 2026 and is expected to reach USD 6.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.14% from 2026 to 2033.

Clinical mass spectrometry plays a vital role in the drug discovery pipeline for development of personalized medicines. It is further used in live imaging of biological tissue samples for detection of biomarkers. Cost reduction and improved assay quality are the key factors driving the adoption of mass spectrometry technique. According to the American Association for Clinical Chemistry (AACC), the greater specificity of liquid chromatography-mass spectrometry (LC-MS) enables the measuring of testosterone in the patients with low endogenous concentrations. This technique is more reliable than traditional immunoassays, especially in women and children. This has led to an early adoption of the most recent generation of instruments using an established technology in the laboratories.

Clinical diagnostic mass spectrometers have the potential to analyze limited range of samples such as biomarkers, proteins or drug molecules at once, and in

Some cases with low concentrations. Thus, these devices are a valuable tool in diagnostics and laboratory settings. Furthermore, it allows researchers to determine pharmacokinetic profiles of drugs that are administered in micro doses. The technology shift from traditional systems to high-resolution technologies such as Quadrupole-time of flight (Q-TOF) mass spectrometry and the demand for this spectrometry technique type is expected to grow rapidly owing to advantages such as accuracy, improved resolution, and sensitivity for clinical diagnostic applications.

Market Dynamics

Technological advancements and product launches by key players are expected to drive growth of the clinical mass spectrometry market. Advancements in technology include miniaturization of mass spectrometry instruments and increasing automation within spectrometric units to reduce human efforts and improve efficiency of the instrument. For instance, a fully automated analyzer launched by Thermo Fisher, in June 2017 that can be customized for compatibility with laboratory information systems.

Key features of the study

• This report provides in-depth analysis of the global clinical mass spectrometry market size (US$ Mn), and compound annual growth rate (CAGR (%)) over the forecast period: 2026 - 2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global clinical mass spectrometry market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
• Key players covered as a part of this study include Bruker Corporation Kore Technology Limited, Bergman Messgerate Entwicklung KG, Mass Spectrometry Instruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies, and Danaher Corporations
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, market expansion, and marketing tactics
• The global clinical mass spectrometry report caters to various stakeholders in this industry which include investors, product manufacturers, distributors, and suppliers of clinical mass spectrometry, research and consulting firms, new entrants, and financial analysts.

Market Segmentation

• By Product Type
  • Gas chromatography-mass spectrometry (GC-MS) instrument
  • Liquid chromatography-mass spectrometry (LC-MS) instrument
  • Maldi TOF mass spectrometer
  • Capillary electrophoresis-mass spectrometry
  • Ion mobility spectrometry-mass spectrometry
• By Application
  • Clinical Testing
  • Proteomics
  • Drug Discovery
• By End User
  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Clinical Mass Spectrometry Market - Competitive Landscape
  • Bruker Corporation
  • Kore Technology Limited
  • Bergman Messgerate Entwicklung KG
  • Mass Spectrometry Instruments (MSI)
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Danaher Corporations

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Landscape
• Porter's Five Forces Model

4. Global Clinical Mass Spectrometry Market, By Product Type, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2017 - 2033
  • Segment Trends
• Gas chromatography-mass spectrometry (GC-MS) instrument
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
• Liquid chromatography-mass spectrometry (LC-MS) instrument
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
• Maldi TOF mass spectrometer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
• Capillary electrophoresis-mass spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
• Ion mobility spectrometry-mass spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)

5. Global Clinical Mass Spectrometry Market, By Application, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2017 - 2033
  • Segment Trends
• Clinical Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
• Proteomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)

6. Global Clinical Mass Spectrometry Market, By End User, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2017 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
• Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)

7. Global Clinical Mass Spectrometry Market, By Region, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, By Region, 2018- 2033
  • Regional Trends
• North America
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Africa
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa
• Middle East
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East

8. Competitive Landscape

• Company Profiles
  • Bruker Corporations
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Kore Technologies
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Bergman Messgerate Entwicklung KG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Mass Spectrometry Instruments (MSI)
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • RGB Photonics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • ABLE Biosciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Danaher Corporations
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Agilent Technologies
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Shimadzu Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • PerkinElmer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Analyst Views

9. Section

• References
• Research Methodology
• About Us and Sales Contact